Polydex Pharmaceuticals Release: Ushercell Clinical Trial Updates Presented At International Microbicide Conference

Polydex Pharmaceuticals Limited (NASDAQ: POLXF) is pleased to provide an update on the status of clinical trials, from abstracts presented at this year’s Microbicides 2006 conference, which was held in Cape Town, South Africa.

MORE ON THIS TOPIC